| First Author | Swisa A | Year | 2017 |
| Journal | J Clin Invest | Volume | 127 |
| Issue | 1 | Pages | 230-243 |
| PubMed ID | 27941241 | Mgi Jnum | J:239845 |
| Mgi Id | MGI:5881864 | Doi | 10.1172/JCI88015 |
| Citation | Swisa A, et al. (2017) PAX6 maintains beta cell identity by repressing genes of alternative islet cell types. J Clin Invest 127(1):230-243 |
| abstractText | Type 2 diabetes is thought to involve a compromised beta cell differentiation state, but the mechanisms underlying this dysfunction remain unclear. Here, we report a key role for the TF PAX6 in the maintenance of adult beta cell identity and function. PAX6 was downregulated in beta cells of diabetic db/db mice and in WT mice treated with an insulin receptor antagonist, revealing metabolic control of expression. Deletion of Pax6 in beta cells of adult mice led to lethal hyperglycemia and ketosis that were attributed to loss of beta cell function and expansion of alpha cells. Lineage-tracing, transcriptome, and chromatin analyses showed that PAX6 is a direct activator of beta cell genes, thus maintaining mature beta cell function and identity. In parallel, we found that PAX6 binds promoters and enhancers to repress alternative islet cell genes including ghrelin, glucagon, and somatostatin. Chromatin analysis and shRNA-mediated gene suppression experiments indicated a similar function of PAX6 in human beta cells. We conclude that reduced expression of PAX6 in metabolically stressed beta cells may contribute to beta cell failure and alpha cell dysfunction in diabetes. |
